BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34453582)

  • 1. Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids.
    Zhao J; Lu W; Ren Y; Fu Y; Martens YA; Shue F; Davis MD; Wang X; Chen K; Li F; Liu CC; Graff-Radford NR; Wszolek ZK; Younkin SG; Brafman DA; Ertekin-Taner N; Asmann YW; Dickson DW; Xu Z; Pan M; Han X; Kanekiyo T; Bu G
    Acta Neuropathol; 2021 Nov; 142(5):807-825. PubMed ID: 34453582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid.
    Zhao N; Attrebi ON; Ren Y; Qiao W; Sonustun B; Martens YA; Meneses AD; Li F; Shue F; Zheng J; Van Ingelgom AJ; Davis MD; Kurti A; Knight JA; Linares C; Chen Y; Delenclos M; Liu CC; Fryer JD; Asmann YW; McLean PJ; Dickson DW; Ross OA; Bu G
    Sci Transl Med; 2020 Feb; 12(529):. PubMed ID: 32024798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE deficiency impacts neural differentiation and cholesterol biosynthesis in human iPSC-derived cerebral organoids.
    Zhao J; Ikezu TC; Lu W; Macyczko JR; Li Y; Lewis-Tuffin LJ; Martens YA; Ren Y; Zhu Y; Asmann YW; Ertekin-Taner N; Kanekiyo T; Bu G
    Stem Cell Res Ther; 2023 Aug; 14(1):214. PubMed ID: 37605285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids.
    Zhao J; Fu Y; Yamazaki Y; Ren Y; Davis MD; Liu CC; Lu W; Wang X; Chen K; Cherukuri Y; Jia L; Martens YA; Job L; Shue F; Nguyen TT; Younkin SG; Graff-Radford NR; Wszolek ZK; Brafman DA; Asmann YW; Ertekin-Taner N; Kanekiyo T; Bu G
    Nat Commun; 2020 Nov; 11(1):5540. PubMed ID: 33139712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology.
    Jin Y; Li F; Sonoustoun B; Kondru NC; Martens YA; Qiao W; Heckman MG; Ikezu TC; Li Z; Burgess JD; Amerna D; O'Leary J; DeTure MA; Zhao J; McLean PJ; Dickson DW; Ross OA; Bu G; Zhao N
    Acta Neuropathol; 2022 Jun; 143(6):641-662. PubMed ID: 35471463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis.
    Lloyd GM; Long B; Quintin S; Sorrentino ZA; Gorion KM; Bell BM; Carrillo D; Sullivan P; Borchelt D; Giasson BI
    Acta Neuropathol Commun; 2023 Jul; 11(1):119. PubMed ID: 37482615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice.
    Gong JS; Kobayashi M; Hayashi H; Zou K; Sawamura N; Fujita SC; Yanagisawa K; Michikawa M
    J Biol Chem; 2002 Aug; 277(33):29919-26. PubMed ID: 12042316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
    Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
    J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Sienski G; Narayan P; Bonner JM; Kory N; Boland S; Arczewska AA; Ralvenius WT; Akay L; Lockshin E; He L; Milo B; Graziosi A; Baru V; Lewis CA; Kellis M; Sabatini DM; Tsai LH; Lindquist S
    Sci Transl Med; 2021 Mar; 13(583):. PubMed ID: 33658354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Culture Variabilities of Human iPSC-Derived Cerebral Organoids Are a Major Issue for the Modelling of Phenotypes Observed in Alzheimer's Disease.
    Hernández D; Rooney LA; Daniszewski M; Gulluyan L; Liang HH; Cook AL; Hewitt AW; Pébay A
    Stem Cell Rev Rep; 2022 Feb; 18(2):718-731. PubMed ID: 33725267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathies.
    Hass EW; Sorrentino ZA; Xia Y; Lloyd GM; Trojanowski JQ; Prokop S; Giasson BI
    Acta Neuropathol Commun; 2021 Aug; 9(1):146. PubMed ID: 34454615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERβ and ApoE isoforms interact to regulate BDNF-5-HT
    Chhibber A; Zhao L
    Alzheimers Res Ther; 2017 Sep; 9(1):79. PubMed ID: 28934977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain.
    Gerritsen G; Kypreos KE; van der Zee A; Teusink B; Zannis VI; Havekes LM; van Dijk KW
    J Lipid Res; 2003 Feb; 44(2):408-14. PubMed ID: 12576523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoform-Dependent Effects of Apolipoprotein E on Sphingolipid Metabolism in Neural Cells.
    Kurano M; Tsukamoto K; Sakai E; Hara M; Yatomi Y
    J Alzheimers Dis; 2022; 85(4):1529-1544. PubMed ID: 34958030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S; Abraham CR; Zannis VI
    Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicle trafficking and lipid metabolism in synucleinopathy.
    Fanning S; Selkoe D; Dettmer U
    Acta Neuropathol; 2021 Apr; 141(4):491-510. PubMed ID: 32607605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
    Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
    Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ApoE isoforms differentially regulates cleavage and secretion of BDNF.
    Sen A; Nelson TJ; Alkon DL
    Mol Brain; 2017 Jun; 10(1):19. PubMed ID: 28569173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between APOE Variants, Tau and α-Synuclein.
    Rodriguez-Vieitez E; Nielsen HM
    Adv Exp Med Biol; 2019; 1184():177-186. PubMed ID: 32096038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.